The Claim
In post-menopausal women with elevated dp-ucMGP, daily supplementation with 180 µg menaquinone-7 for one year significantly reduces brachial and carotid artery blood pressure by approximately 3–4.5% compared to placebo, with the greatest reductions occurring in individuals with the highest baseline arterial stiffness.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In post-menopausal women with high levels of dp-ucMGP, taking 180 micrograms of menaquinone-7 daily for one year lowers blood pressure in the arm and neck arteries by 3–4.5% compared to a placebo, with the largest drops seen in those with the stiffest arteries at the start.
See the scientific wording
In post-menopausal women with elevated dp-ucMGP, daily 180 µg menaquinone-7 supplementation for one year significantly lowers brachial and carotid artery blood pressure by approximately 3–4.5% compared to placebo, with the greatest reductions observed in those with the highest baseline arterial stiffness.
Vitamin K2 activates a protein that binds calcium in artery walls, preventing calcium buildup that stiffens arteries; softer arteries allow blood to flow more easily, which lowers blood pressure.
What the research says
1 studyIn women after menopause with stiff arteries, taking a daily vitamin K2 supplement for a year slightly lowered their blood pressure, especially in those whose arteries were already the stiffest. The study proves it works.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.